24 Coronaviruses recently emerged as major human pathogens causing outbreaks 25 of severe acute respiratory syndrome and Middle-East respiratory syndrome. 26 They utilize the spike (S) glycoprotein anchored in the viral envelope to mediate 27 host attachment and fusion of the viral and cellular membranes to initiate 28 infection. The S protein is a major determinant of the zoonotic potential of 29 coronaviruses and is also the main target of the host humoral immune response. 30 We report here the 3.5 Å resolution cryo-electron microscopy structure of the S 31 glycoprotein trimer from the pathogenic porcine deltacoronavirus (PDCoV), which 32 belongs to the recently identified delta genus. Structural and glycoproteomics 33 data indicate that the glycans of PDCoV S are topologically conserved when 34 compared with the human respiratory coronavirus HCoV-NL63 S, resulting in 35 similar surface areas being shielded from neutralizing antibodies and implying 36 that both viruses are under comparable immune pressure in their respective 37 hosts. The structure further reveals a shortened S 2 ' activation loop, containing a 38 reduced number of basic amino acids, which participates to rendering the spike 39 largely protease-resistant. This property distinguishes PDCoV S from recently 40 characterized betacoronavirus S proteins and suggests that the S protein of 41 enterotropic PDCoV has evolved to tolerate the protease-rich environment of the 42 small intestine and to fine-tune its fusion activation to avoid premature triggering 43 and reduction of infectivity. 44 45 46 on November 3, 2017 by UNIV OF NEWCASTLE http://jvi.asm.org/ Downloaded from 3 47 Importance 48
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and subsequent fusion of the viral and cellular membranes, via irreversible 93 conformational changes, initiating viral infection. Since it is the major surface protein, S 94 is also the main target of neutralizing antibodies during infection and a focus of vaccine 95 design. 96
97
The zoonotic potential of coronaviruses is determined by the receptor-binding properties 98 of the S protein. For instance, SARS-CoV and MERS-CoV bind with high-affinity to their 99 cognate human receptors, angiotensin-converting enzyme 2 (ACE2) and dipeptidyl 100 peptidase 4 (DPP4), respectively (4, 5) . Metagenomic data revealed that many MERS-101
CoV and SARS-CoV-like viruses exist in bats and one such virus, WIV-1, isolated from 102 bat feces, shares 99.9% nucleotide sequence identity with SARS-CoV. The S protein 103 encoded by WIV-1 binds human, bat and civet ACE2 orthologues allowing the virus to 104 efficiently infect human cells expressing any of these three orthologues (6, 7) . Similarly, 105
HKU4-CoV and HKU5-CoV that are closely related to MERS-CoV have been identified 106 in bats and HKU4-CoV can be adapted to bind human DPP4 by substituting three 107 amino acids in the S receptor-binding domain (8, 9) . 108 6 For a subset of coronaviruses, such as MHV, the S 116 glycoprotein is cleaved at the S 1 /S 2 junction during biogenesis and viral egress (10) (11) (12) (13) . 117
This proteolytic event, along with subsequent binding to the host receptor, enhances 118 processing at the S 2 ' site and participates in MERS-CoV or SARS-CoV fusion 119 activation (11, 13) . Moreover, substitution of two residues at the boundary between the 120 S 1 and S 2 subunits enables efficient processing by human proteases and allows the bat-121 infecting HKU4-CoV S protein to mediate entry into human cells (14) . are key events orchestrating spatial and temporal activation of fusion to ensure 130 One common pattern shared by both SARS and MERS outbreaks is that although they 138 both originated in bats, an intermediate host with closer physical proximity to humans 139 allowed for more efficient cross-species transmission. Palm civets and camels were the 140 most probable intermediate hosts for respectively(7, 17, 141 18 ). Due to their proximity with humans, pigs also acted as intermediate hosts for the 142 influenza pandemic (19) and for the emergence of Nipah virus in Malaysia(20) . To date, 143 only -and -coronaviruses have been implicated in human diseases and several S 144 glycoproteins from viruses belonging to these two genera have been structurally 145 characterized (21) (22) (23) (24) (25) (26) . To the best of our knowledge, no porcine coronaviruses have 146 crossed the species barrier to infect humans, and their receptor usage appears to favor 147 porcine orthologues. Porcine epidemic diarrhea virus (PEDV), however, can infect pig, 148 human, monkey and bat cells, suggesting it has the potential to spillover to species 149 other than pig (27) . As a result, cross-species transmission of coronaviruses poses an 150 imminent and long-term threat to human health which emphasizes the need for 151 surveying and studying these viruses to prevent and control infections. 152
153
The recently emerged porcine deltacoronavirus (PDCoV) is responsible for diarrhea in 154 piglets and has had devastating consequences for the swine industry worldwide (28, 29). 155 No vaccines or treatments are available for PDCoV. Here, we report the cryoEM 156 structure of the PDCoV S trimer revealing that it has a molecular architecture most 157 closely related to the S glycoproteins of the α-genus of coronaviruses. Integrating 158 structural and glycoproteomics data, we discovered that PDCoV S masks potential 159 epitopes with glycans in a way reminiscent of the human respiratory α-coronavirus 160 on November 3, 2017 by UNIV OF NEWCASTLE http://jvi.asm.org/ Downloaded from . These results support a relatedness between αand -161 coronavirus S glycoproteins and suggest that the immune system of infected hosts exert 162 comparable selection pressure on these viruses which has led to these adaptations. 163
The structure also reveals the C-terminal S 2 fusion machinery of the PDCoV S protein 164 features a short S 2 ' activation loop which appears to be largely resistant to proteolysis 165 by trypsin/chymotrypsin. We conclude that PDCoV has evolved to be highly adapted to 166 the protease-rich environment of the enteric tract to ensure proper spatial and temporal 167 activation of fusion and prevent premature triggering which would significantly impact 168 virus infectivity. 169
170

Results
171
Structure determination of the PDCoV S glycoprotein 172
PDCoV was first identified in Hong Kong in 2012(29) and it has since spread rapidly in 173 the swine population across the globe (28, 29) . Due to its recent emergence, relatively 174 little is known about this virus compared to other swine coronaviruses. One feature that 175 distinguishes PDCoV from other known coronaviruses is that it encodes one of the 176 smallest S glycoproteins. We therefore set out to explore the architectural diversity of S 177 proteins across coronavirus genera to understand shared and unique features of the 178 structurally uncharacterized -genus. 179
180
We used Drosophila S2 cells to produce the PDCoV/USA/Illinois121/2014 S 181 ectodomain (residues 1-1098) with a C-terminal fusion adding a GCN4 trimerization 182 motif and a strep-tag(30). Following sample vitrification by triple blotting(31), data were 183 on November 3, 2017 by UNIV OF NEWCASTLE http://jvi.asm.org/ Downloaded from acquired on an FEI Titan Krios electron microscope equipped with a Gatan Quantum 184 GIF energy filter operated in zero-loss mode and a Gatan K2 Summit electron-counting 185 camera operated in super-resolution mode (Fig 1A-B ). We determined a 3D 186 reconstruction at 3.5 Å resolution resolving most amino acid side chains, disulphide 187 bonds and N-linked glycans ( Fig S1A) . These features were used as fiducials to confirm 188 the sequence register during model building ( Fig 1C-F The PDCoV S protein assembles as a compact trimer with a height of ~145 Å and a 194 width of 115 Å ( Fig 1C-D) . The S 1 subunit has a modular organization comprising four 195 distinct domains, designated A, B, C and D, whereas the S 2 subunit adopts a mostly-196 helical elongated architecture with a connector domain appended to its C-terminal 197 end(21, 22) ( Fig 1E-F) . Table S1 ). Combining our structural and mass-spectrometry data, 207
we found evidence for glycosylation at 26 out of 27 possible NXS/T glycosylation 208 sequons. The intact glycopeptides detected by MS/MS for PDCoV S expressed in 209
Drosophila S2 cells corresponded mostly to paucimannosidic glycans containing 3 210 mannose residues (with or without core fucosylation) and oligomannose glycans 211 containing 4 to 9 mannose residues. We also detected complex glycans (with or without 212 core fucosylation), which appears compatible with the accessibility and crowding of 213 these carbohydrate chains that would permit processing (35, 36) . has doubled its number of glycosylation sites since the 1968 pandemic although its 225 amino acid sequence remains ~88% identical(37). There is considerable sequence 226 divergence between the HCoV-NL63 and PDCoV S glycoproteins, which share 43% 227 amino acid sequence identity. The observation that numerous glycosylation sites are 228 conserved between the two proteins suggest that -and -coronaviruses could face 229 on November 3, 2017 by UNIV OF NEWCASTLE http://jvi.asm.org/ Downloaded from similar immune pressure in their respective hosts, and that the areas that are masked 230 by the conserved glycans are key to the function of these S glycoproteins. Based on the 231 information gained from the HCoV-NL63 S structure(22), for which glycans appears to 232 contribute to masking the receptor-binding loops from antibody recognition, we suggest 233 that the glycan shield of PDCoV S and other coronavirus S glycoproteins could assist in 234 immune evasion similarly to the well-characterized HIV-1 envelope trimer (35, 36) . 235 236 Finally, coronavirus S glycans have previously been proposed to participate in host cell 237 entry(38), since L-SIGN lectin can be used as an alternative receptor by SARS-CoV(39) 238
and HCoV-229E(40), and it is conceivable they play a similar role for other S proteins. 239 240
Architecture of the S 1 receptor-binding subunit 241
The PDCoV and HCoV-NL63 S 1 subunits exhibit strikingly similar structures 242 (r.m.s.d.=2.7 Å over 448 aligned C positions), except for the absence of the N-terminal 243 domain 0 in the former glycoprotein ( Fig 3A) . Deletion of domain 0, which is responsible 244 for attachment to sialoglycans, in the porcine transmissible gastro-enteritis virus (TGEV) 245 S gene, gave rise to porcine respiratory coronavirus (PRCV) and in turn resulted in a 246 loss of enteric tropism (41, 42) . PDCoV and HCoV-NL63, however, exhibit opposite 247 behavior, as they target the enteric or the respiratory tracts despite the absence or 248 presence of a domain 0 in their S glycoproteins, respectively. We describe below the 249 functionally-relevant similarities and differences detected in the PDCoV S structure 250 relative to other coronavirus S structures. 251 252 on November 3, 2017 by UNIV OF NEWCASTLE http://jvi.asm.org/ Downloaded from Domain A is located at the viral membrane distal side and account for a large part of the 253 exposed surface area of the S 1 subunit. It folds as a galectin-like -sandwich 254 supplemented with a helix on the viral membrane distal side and a three-stranded 255 antiparallel -sheet plus a helix on the proximal side. The domain A surface is heavily 256 glycosylated and features 7 glycans for PDCoV ( Fig 3D) . We previously reported that 257
the HCoV-NL63 S glycan linked to Asn358 (domain A) points towards the receptor-258 binding domain B, masking residues involved in receptor recognition. A marked 259 difference between the A domains of PDCoV S and HCoV-NL63 S is that the -hairpin 260
harboring Asn358 in HCoV-NL63 S features a deletion of 10 residues significantly 261 shortening it in PDCoV S ( Fig 3A-C) . Moreover, the topologically equivalent glycan 262 linked to residue Asn-184 of PDCoV S is protruding away from domain B and does not 263 significantly cover it, in contrast to what was observed for HCoV-NL63 ( Fig 3A-C) . 264 265 OC43, HKU1 and bovine coronavirus (BCoV) are known to use 9-O-acetyl-sialylated 266 cellular receptors for attachment to host cells(43, 44). Structural and biochemical 267 studies showed that domain A mediates these interactions and mapped key residues 268 involved(25, 45) and nanoparticle-displayed multimeric OC43 S 1 subunit exhibited high 269 hemagglutination titer ( Fig. 3 F) . Comparison of the PDCoV, HKU1 and BCoV domain A 270 structures indicated PDCoV cannot interact with 9-O-acetyl-sialoglycans in a similar way 271 due to the absence of the strictly conserved residues involved in binding (BCoV Tyr162, 272
Glu182, Trp184 and His185) and of the loops delineating the binding cavity ( Fig. 3 
D-E). 273
In line with this observation, isolated or nanoparticle-displayed multimeric PDCoV S 1 274 subunit failed to interact with sialic acid using an erythrocyte hemagglutination assay with the HCoV-NL63 S glycans linked to Asn-486 and Asn-512, respectively. PRCV and 284 TGEV B domains also feature topologically similar glycosylation sites on the solvent 285 exposed surface of the β-sandwich and these glycans are likely to limit the immune 286 response against this domain which is known to be the target of neutralizing antibodies 287 for several coronaviruses(47-52). The glycan linked to Asn-506 in HCoV-NL63 S is 288 absent in PDCoV S for which the equivalent residue is Ser-325 ( Fig 4A and C) . Since 289 masking of receptor-binding residues has been suggested to assist HCoV-NL63 290 immune evasion (22), the reduced overall glycan coverage of PDCoV domain B could 291 result from weaker immune pressure directed at the receptor-binding region in pigs 292 compared to HCoV-NL63 S in humans. 293
294
Previous work showed that the loops located at the viral membrane distal end of the -295 sandwich of domain B in -coronavirus S glycoproteins are responsible for binding to 296 diverse host receptors such as ACE2 (HCoV-NL63)(46) or pAPN (PRCV/TGEV)(47). 297
Although the distal loops are significantly shorter for PDCoV compared to these two -298 on November 3, 2017 by UNIV OF NEWCASTLE http://jvi.asm.org/ Downloaded from coronaviruses, loop 1 and loop 3 contain several aromatic residues ( Fig 4A-D) . Since 299 aromatic residues in these loops have been shown to directly participate in receptor-300 binding for HCoV-NL63, PRCV and TGEV, we speculate that they could also mediate 301
interactions of the PDCoV B domain with its receptor. As is the case for HCoV-NL63 S, 302 the PDCoV B domain has an opposite orientation, related by a ~180˚ rotation, to the 303 equivalent domain of -coronavirus S glycoproteins (21). This results in burying the 304 distal loops of the -sandwich through interactions with domain A belonging to the same 305 protomer and in turn restrain the availability of the putative receptor-binding motif to 306 interact with the receptor (Fig 3B-C) . As a result, it is likely that PDCoV and HCoV-NL63 307 S glycoproteins can undergo similar conformational changes to those described for 308 domain B of SARS-CoV and MERS-CoV S to interact with their cognate receptors(23, 309 24, 26). A major difference, however, is that -coronavirus S using domain B as 310 receptor-binding domain appear to spontaneously undergo these rearrangements 311
whereas -and -coronavirus S do not and rely on a yet unidentified stimulus (22). 312 313
Organization of the S 2 fusion machinery 314
The C-terminal S 2 subunit trimer fuses the viral and cellular membranes at the onset of 315 infection and is the most conserved region among coronavirus S glycoproteins. The 316
PDCoV S 2 subunit is structurally similar to α-and β-coronavirus S 2 subunits such as 317
HCoV-NL63 (22) fusion machinery across multiple genera highlights that coronaviruses rely on a 320 common fusion mechanism to enter host cells(53). Despite these striking similarities, 321 on November 3, 2017 by UNIV OF NEWCASTLE http://jvi.asm.org/ Downloaded from coronavirus fusion machineries exhibit differences with key functional implications for 322 their activation mechanism and potential for zoonotic spillover. 323
324
The S 2 ' activation loop, which connects the upstream helix to the fusion peptide and 325 regulates the spatial and temporal activation of fusion, is resolved in the PDCoV S 326 cryoEM map ( Fig 5A-B) , as was the case for the HCoV-NL63 S(22) and SARS-CoV S 327 structures(23, 24). However, the PDCoV S 2 ' loop is short (LTTRIGGR) and comprises 6 328 and 3 fewer residues than the HCoV-NL63 S (LPQRNIRSSRIAGR) and SARS-CoV S 329 (ILPDPLKPTKR) counterparts, respectively. In addition, the S 2 ' loop of these viruses 330 contains multiple positive charges, including two putative furin cleavage sites for HCoV-331 NL63 S, whereas the PDCoV S 2 ' loop harbors a single positively charged residue (Arg-332 669) in addition to the conserved Arg-673 residue (Fig 5A-B) . These structural features 333 allow rationalizing the known protease requirements for fusion activation of the HCoV-334 NL63 S glycoprotein, which is preferentially cleaved by furin in the endosomes, and of 335 the SARS-CoV S glycoprotein, which is preferentially processed by cathepsin L in the 336 endo-lysosomes, and explain the fact that trypsin-like TMPRSS proteases can also 337 trigger both proteins(10, 15). The paucity of positive charges in the PDCoV S 2 ' trigger 338 loop is in line with the requirement for trypsin or other pancreatic proteases to allow 339 virus passaging and the fact that PDCoV is exposed to high concentration of such 340 proteases in the enteric tract of infected pigs (28) (14). Notably, the PDCoV S glycans linked to Asn-652 and Asn-661 346 decorate the trimer surface near the S 2 ' trigger loop and could limit accessibility to 347 proteases and play a role in orchestrating fusion activation ( Fig 5B) . These glycans are 348 conserved with an identical structural organization in HCoV-NL63 S and may have the 349 same putative function (22). directly interact with domain A from the same subunit to potentially limit accessibility of 382 the receptor-binding loops to neutralizing antibodies. Sequence analysis indicates a 383 strict correlation of the presence or absence of the HR1/HR2 insertions in the S 384 glycoprotein sequence and an apparent evolutionary pressure restricting 385 insertions/deletions to heptad-repeat units which we postulate to be necessary for 386 efficient S refolding and fusion. Based on these criteria, we put forward that -and -387 coronavirus S glycoproteins share closer evolutionary relationships with each other than 388 they do with S of the other two coronavirus genera although insertions in HR1 and HR2 389 have also been detected in a subset of -coronavirus S proteins. conditions, which led to spontaneous refolding into post-fusion S 2 trimers (the ground 394 state of the fusion reaction)(53). In contrast, the PDCoV S glycoprotein remained largely 395 uncleaved even after extended incubation times with up to 5:1 molar ratio of S to trypsin 396 or chymotrypsin (0.1 mg/ml) ( Figure 6 ). These results suggest that fusion activation of 397
PDCoV S, which is believed to be promoted by trypsin (28), involves an additional step 398 to expose the S 2 ' cleavage site, such as the receptor-binding induced conformational 399 changes described for MERS-CoV(13), SARS-CoV(57), MHV(58) and PEDV(16) . 400
These distinct protease sensitivities are reminiscent of the differences reported between 401 clinical isolates (CV777) and cell-culture adapted (caDR13) PEDV strains for which 402 infectivity strictly requires or is hampered by trypsin, respectively(16). We put forward 403 that the S glycoprotein sequence and in turn structure of PDCoV and PEDV CV777 404 have evolved to be resistant to pancreatic proteases to which both viruses are exposed 405 in the enteric tract during infection. Fine-tuning of fusion activation is likely achieved by 406 restraining access to the S 2 ' cleavage site until receptor-binding occurs at the host cell 407 surface. This event could promote conformational changes exposing the S 2 ' site to allow 408 processing by trypsin or other proteases with exquisite spatial and temporal 409 coordination. In contrast, SARS-CoV, MERS-CoV or MHV are not expected to be 410 exposed to pancreatic proteases during the virus life-cycle and their S glycoproteins 411 presumably did not evolve with this selection pressure, explaining their sensitivity to Frame alignment was carried out using Motioncor2(64). The parameters of the 487 microscope contrast transfer function were initially estimated using GCTF(65) and then 488 using CTFFIND4(66). Particles were automatically picked using DoGPicker(67). Particle 489 images were extracted and processed using Relion 2.0(68) with a box size of 640 490 pixels 2 and a pixel size of 0.665 Å. Following reference-free 2D classification, we ran 3D 491 classification with C1 symmetry(69) using an initial model generated with 492 e2initialmodel.py in EMAN2. 455,710 particles were selected to run a gold-standard 3D 493 refinement imposing C3 symmetry using Relion 2.1 (70) that led to a map at 3.5 Å 494 resolution. Post processing was done using Relion to apply an automatically generated 495 B factor of -150 Å 2 . Reported resolutions are based on the gold-standard FSC=0.143 496 criterion(70, 71) and Fourier shell correlation curves were corrected for the effects of 497 soft masking by high-resolution noise substitution(72). The soft mask used for FSC 498 calculation had a 10 pixel cosine edge fall-off. 499 500 Model building and analysis 501 UCSF Chimera(73) was used to fit the HCoV-NL63 S structure(22) into the cryoEM map 502 before manual rebuilding in Coot(32, 74) . Glycan density coming after an NXS/T motif 503 was initially hand built into the density where visible and glycan geometry was then 504 refined using Rosetta, optimizing the fit-to-density as well as the energetics of 505 on November 3, 2017 by UNIV OF NEWCASTLE http://jvi.asm.org/ Downloaded from protein/glycan contacts. The final model was refined using the symmetric modeling 506 framework in Rosetta(33, 75) . The quality of the final model was analyzed with 507 Molprobity(76) and Privateer(77). All figures were generated with UCSF Chimera(73). 508 509 Mass Spectrometry 510 250 pmol of PDCoV S was incubated in a freshly prepared solution containing 100mM 511
Tris pH 8.5, 2% sodium deoxycholate, 10mM tris(2-carboxyethyl)phosphine, and 40mM 512 iodoacetamide at 95 C for five minutes followed by 25 C for thirty minutes in the dark. 513 80 pmol of denatured, reduced, and alkylated PDCoV S was then diluted into freshly 514 made 50mM ammonium bicarbonate and incubated for 14 hours at 37 C either with 515 1:75 (w:w) of trypsin (Sigma Aldrich), or chymotrypsin (Sigma Aldrich) or alpha lytic 516 protease (Sigma Aldrich). Formic acid was then added to a final concentration of 2% to 517 precipitate the sodium deoxycholate in the samples, followed by centrifugation at 14,000 518 rpm for 20 minutes. The supernatant containing the (glyco)-peptides was collected and 519 spun again at 14,000 rpm for 5 min immediately before sample analysis. For each 520 sample 8 µL was injected on a Thermo Scientific Orbitrap Fusion Tribrid mass 521 spectrometer. A 35-cm analytical column and a 3-cm trap column filled with ReproSil-522
Pur C18AQ 5 μm (Dr. Maisch) beads were used. Nanospray LC-MS/MS was used to 523 separate peptides over a 110-min gradient from 5% to 30% acetonitrile with 0. two missed cleavages, with EThcD fragmentation (b/y-and c/z-type ions). We used a 536 precursor mass and product mass tolerance of 12 ppm and 24 ppm respectively. 537
Carbamidomethylation of cyteines was set as fixed modification, methionine oxidation 538 as variable modification, and all four software-provided N-linked glycan databases were 539 combined into a single non-redundant list used to identify glycopeptides. All 540 glycopeptide hits were manually inspected and only those with quality peptide sequence 541 information are reported here. 542 543
Proteolysis of PDCoV S and SARS S glycoproteins 544
Proteins at a concentration of 0.5 mg/mL (PDCoV S) or 1mg/mL (SARS-CoV S) were 545 incubated with 0.1 mg/mL of either trypsin (SigmaAldrich) or chymotrypsin at 22 °C for 546 two hours. This reaction was then used for analysis by SDS-PAGE. 
